Burlingame, CA, Sept. 04, 2025 (GLOBE NEWSWIRE) — The Global DNA Manufacturing Market is estimated to be valued at USD 6.44 Bn in 2025 and is expected to reach USD 19.56 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 17.2% from 2025 to 2032. The DNA manufacturing market is driven by growing demand for gene therapies, vaccines, and personalized medicine, alongside rapid advancements in synthetic biology and CRISPR-based technologies. Rising investments in genomics research, expanding applications in drug discovery, and the increasing prevalence of genetic disorders further fuel market growth. Additionally, government funding, biopharma partnerships, and the need for scalable, cost-efficient DNA synthesis solutions are key contributors to its expansion.
Request a Sample Copy of this Report at: https://www.coherentmarketinsights.com/insight/request-sample/8428
Global DNA Manufacturing Market Key Takeaways
Registering a CAGR of 17.2%, the global DNA manufacturing market size is projected to grow from USD 6.44 Bn in 2025 to USD 19.56 Bn by 2032.
Synthetic DNA segment is expected to account for nearly half of the global DNA manufacturing market share by 2025.
Oncology is slated to remain the most lucrative application of DNA manufacturing, accounting for 24.3% of the market revenue share in 2025.
Based on technology, PCR segment is projected to lead the industry, capturing nearly one-third of the market share by 2025.
North America, with an estimated market share of 38.5% in 2025, is set to maintain its dominance over the global DNA manufacturing industry.
Asia Pacific is expected to emerge as the most lucrative pocket for DNA manufacturing companies during the assessment period.
Rising Demand for Cell and Gene Therapies Spurring Market Growth
According to Coherent Market Insights (CMI), the DNA manufacturing market outlook appears promising. This is mainly due to rising prevalence of chronic and genetic diseases and increasing demand for cell and gene therapies.
Advanced therapies like cell therapy and gene therapy are witnessing a higher demand due to rising incidence of cancer, genetic disorders, and rare diseases. This trend is expected to boost growth of the DNA manufacturing market.
Cell and gene therapies often require plasmid DNA and viral vectors. Thus, their growing popularity for treating a wide range of diseases is set to drive the need for DNA manufacturing during the forthcoming period.
High Production Costs Restraining DNA Manufacturing Market Growth
Despite a strong growth trajectory, certain factors might slow down growth of the DNA manufacturing market. High cost of DNA synthesis is one such factor.
Producing high-quality DNA, especially for clinical applications, is a complicated and expensive process. This makes it harder for DNA to be widely used in therapies and research, which can slow down DNA manufacturing market growth in some regions.
Purchase Now Up to 25% Discount on This Premium Report @ https://www.coherentmarketinsights.com/insight/buy-now/8428
Technological Advancements Creating New Growth Prospects
Advances in genetic engineering and synthetic biology are changing the way DNA is manufactured. They allow scientists to create custom DNA sequences for uses like medical tests and gene therapies.
Companies like GenScript and Twist Bioscience lead from the forefront when it comes to developing advanced platforms that speed up synthesis of long and complex DNA sequences. These innovations are expected to unlock new revenue streams for DNA manufacturing …